Table 1 Baseline characteristics of patients with lacrimal gland carcinoma
Total (n = 18) | Patient number | Percentage (%) |
|---|---|---|
Median age (years) | 54 (20–85) | |
Sex | ||
Male | 8 | 44.4 |
Female | 10 | 55.6 |
T stage | ||
1 | 1 | 5.6 |
2 | 9 | 50.0 |
3 | 3 | 16.7 |
4 | 5 | 27.7 |
Types of surgery | ||
Excision | 15 | 83.3 |
Needle biopsy | 3 | 16.7 |
RT treatment | ||
Adjuvant RT alone | 13 | 72.2 |
Adjuvant CCRT | 2 | 11.1 |
Definitive RT | 2 | 11.1 |
Definitive CCRT | 1 | 5.6 |
RT type | ||
3DCRT | 2 | 11.1 |
IMRT | 14 | 77.8 |
Proton | 2 | 11.1 |
RT dose | ||
< 6600 cGy | 9 | 50.0 |
≥ 6600 cGy | 9 | 50.0 |
Cell type | ||
Adenoid cystic carcinoma | 9 | 50.0 |
Carcinoma ex pleomorphic adenoma | 7 | 38.9 |
Poorly differentiated adenocarcinoma | 2 | 11.1 |
Margin | ||
positive | 13 | 72.2 |
negative | 5 | 27.8 |
LVSI | ||
Positive | 6 | 33.3 |
Negative | 12 | 66.7 |
PNI | ||
Positive | 8 | 44.4 |
Negative | 10 | 55.6 |